Most of the media continues to focus on the national response to the coronavirus.
The charts of the producer of medical equipment are holding up well, though its shares eventually could run into resistance.
While Johnson & Johnson and other pharma cos. give us hope, here's my wish list to keep the nation safe and the economy ready to go again.
Things will be different after Covid-19 and one change will be in how people care about themselves.
As it gets the OK for a new rapid Covid-19 detecting device, Abbott Labs could be purchased here following our new technical strategy.
Investors seem to be voting with their feet.
While the short-term picture of JNJ suggests more risk is possible, the longer-term patterns are constructive.
The healthcare giant's charts still show some signs of weakness but also indicate it could rally and make a base from a higher level.
The charts of VTR have been hurt.
Our latest strategy on the healthcare staffing company.